Difficulty: Medium
Average Score: 76%
Practice
Patient with diabetes has hyperlipidemia. Which drug of the following cannot be used in his case due to the risk of development of hyperglycemia?
Correct answer
A
Rationale
A' is correct because niacin worsens hyperglycemia by increasing insulin resistance, a contraindication in diabetes, per endocrinology. 'B' (statins), 'C' (colestipol), and 'D' (ezetimibe) have minimal glucose impact. Niacin's metabolic effect limits its use in diabetic hyperlipidemia.